Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.62/Share

Go back to Aclaris Therapeutics (ACRS) Reports Q2 Loss of $0.62/Share
(NASDAQ: ACRS) Delayed: 4.92 --0 (-0%)
Previous Close $4.92    52 Week High $33.88 
Open $4.92    52 Week Low $14.12 
Day High $4.92    P/E N/A 
Day Low $4.92    EPS $0.00 
Volume 15